Nipro Co. (OTCMKTS:NPRRF) Sees Significant Decrease in Short Interest

Nipro Co. (OTCMKTS:NPRRF) saw a significant decrease in short interest during the month of April. As of April 30th, there was short interest totaling 245,672 shares, a decrease of 46.6% from the April 15th total of 460,217 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Nipro Price Performance

OTCMKTS:NPRRF remained flat at $9.96 on Friday. The firm’s fifty day simple moving average is $9.96 and its 200-day simple moving average is $8.86. Nipro has a 12-month low of $9.67 and a 12-month high of $9.96.

Nipro Company Profile

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. The company's Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services.